Home › Funds › Armstrong, Fleming & Moore, Inc › LLY

Armstrong, Fleming & Moore, Inc position in LLY

ELI LILLY & CO · Health Care

Armstrong, Fleming & Moore, Inc reported holding 859 shares of LLY (ELI LILLY & CO) in its Q3 2026 13F filing — a position valued at US$994K, representing 0.33% of its reported portfolio and ranking #40 among its reported holdings. Armstrong, Fleming & Moore, Inc has disclosed LLY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)859 sh
Reported value held$994.48K
Portfolio Weight0.33%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Armstrong, Fleming & Moore, Inc's LLY position evolved

Armstrong, Fleming & Moore, Inc first disclosed a stake in LLY in Q3 2023 at 760 shares (US$408K). The position peaked in Q2 2026 at 929 shares, worth US$1.1M. Across 13 filings, Armstrong, Fleming & Moore, Inc increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 859 shares valued at US$994K — a reduction of -70 shares quarter over quarter.. Notable position changes include a 66% trim in Q1 2025 (shares fell 5% over the following quarter), a 196% increase in Q2 2025 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 760 $408.47K New
Q4 2023 760 $443.29K Hold
Q1 2024 817 $635.97K Add
Q2 2024 830 $751.91K Add
Q3 2024 756 $670.19K Reduce
Q4 2024 756 $584.00K Hold
Q1 2025 255 $210.92K Reduce
Q2 2025 756 $589.69K Add
Q3 2025 896 $684.01K Add
Q4 2025 896 $963.42K Hold
Q1 2026 929 $854.90K Add
Q2 2026 929 $1.11M Hold
Q3 2026 859 $994.48K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LLY and 13F data

LLY (ELI LILLY & CO) is a Health Care company. 36 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), BlackRock Inc (US$81.01B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LLY

All LLY fund holders →

FAQ

How long has Armstrong, Fleming & Moore, Inc held LLY?

Armstrong, Fleming & Moore, Inc has disclosed LLY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Armstrong, Fleming & Moore, Inc's current position in LLY?

As of Q3 2026, Armstrong, Fleming & Moore, Inc holds 859 shares of LLY (ELI LILLY & CO), valued at $994.48K, representing 0.33% of its reported portfolio and ranking #40.

Has Armstrong, Fleming & Moore, Inc been buying or selling LLY?

In the latest 13F filing (Q3 2026), Armstrong, Fleming & Moore, Inc reduced its position in LLY. The position peaked in Q2 2026 at 929 shares.

Which other funds hold LLY?

Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, BlackRock Inc, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.